Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness [NA]

View source ↗

Summary

Clinical trial update for HABIT-ILE plus FST in children with spinal muscular atrophy, noting preliminary effectiveness and current recruitment status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FST
  • HABIT-ILE

Snippet

Sponsor: Teachers College, Columbia University | Conditions: Spinal Muscular Atrophy (SMA) | NA | Status: RECRUITING